Bcl-xL confers multi-drug resistance in several squamous cell carcinoma cell lines

Oral Oncology

Volumn 38, Issue 1, 2002, Pages 41-48

  Noutomi, T ^a,b   Chiba, H ^a,b   Itoh, M ^a,b   Toyota, H ^b   Mizuguchi, J ^b  

^a TOKYO MEDICAL UNIVERSITY HOSPITAL   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Bax ; Bcl xL; Carboplatin; Squamous cell carcinoma

Indexed keywords

CARBOPLATIN; DACTINOMYCIN; ETOPOSIDE; MITOMYCIN C; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS RESISTANCE; DRUG SENSITIVITY; GENE MUTATION; GENE TRANSFER; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOUTH CARCINOMA; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN FAMILY; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC AGENTS; BCL-X PROTEIN; BLOTTING, WESTERN; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; FLOW CYTOMETRY; HUMANS; MOUTH NEOPLASMS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0036143390     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(00)00098-1     Document Type: Article

References (42)

1. Cisplatin/Carboplatin therapy in non-small cell lung cancer
2. Phase I clinical and pharmacokinetic study of high-dose mitoxantrone combined with carboplatin, cyclophosphamide, and autologous bone marrow rescue: High response rate for refractory ovarian carcinoma
3. Carboplatin and radiotherapy in the treatment of head and neck cancer: Six years' experience
4. Cisplatin and DNA repair in cancer chemotherapy
5. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthemia
6. The apoptotic effects of cisplatin and carboplatin in retinoblastoma Y79 cells
7. Participation of Bax-α in IFN-αmediated apoptosis in Daudi B lymphoma cells
8. Social controls on cell survival and cell death
9. Apoptosis in the pathogenesis and treatment of disease
10. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining
11. The proto-oncogene Bcl-2 and its role in regulating apoptosis
12. The Bcl-2 protein family: Arbiters of cell survival
13. Bcl-2 family: Regulators of cell death
14. Bcl-2 family proteins
15. Bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoid and multiple chemotherapeutic drugs
16. Bcl-2 and Bcl-xL can differentially block chemotherapy-induced cell death
17. Induction of the death-promoting gene bax-αsensitizes cultured breast-cancer cells to drug-induced apoptosis
18. Overexpression of Bax enhances antitumor activity of chemotherapeutic agents in human head and neck squamous cell carcinoma
19. p53, The cellular gate keeper for growth and division
20. p53 Expression and cell proliferation in squamous cell carcinomas of head and neck
21. p53 Expression and cell proliferation as prognostic factors in laryngeal squamous cell carconoma
22. Identification of p53 genetic suppressor elements which confer resistance to cisplatin
23. In vivo studies of adenovirus-mediated p53 gene therapy for cis-platinum-resistant human ovarian tumor xenografts
24. Cisplatin-resistant HeLa cells are resistant to apoptosis via p53-dependent and -independent pathways
25. Lack of correlation between cisplatin-induced apoptosis, p53 status and expression of Bcl-2 family proteins in testicular germ cell tumor cell lines
26. Cleavage of Bax-α and Bcl-xL during carboplatin-mediated apoptosis in squamous cell carcinoma cell line
27. A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability
28. Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors
29. Tyrosine protein kinase is involved in anti-IgM-mediated signaling in BAL17 B lymphoma cells
30. Allelotype of breast cancer: Cumulative allele losses promote tumor progression in primary breast cancer
31. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction
32. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
33. Mechanism of apoptosis avoidance in cancer
34. Abrogation of mitochondrial cytochrome c release and caspase-3 activation in acquired multidrug resistance
35. Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceeding nuclear apoptosis induced by chemotherapeutic agents
36. p53 Mutations in human cancers
37. p53 Mutations are associated with 17p allelic loss in grade II and grade III astrocytoma
38. Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma
39. Antisense oligonucleotides as therapeutic agents - Is the bullet really magical?
40. Human Bcl-2 antisense therapy for lymphomas